Brooks Life Science Systems Announces Expansion of Sample Bioprocessing Laboratory Services at its Indianapolis Biorepository

CHELMSFORD, Mass. -- Brooks Life Science Systems announced today the expansion of its sample preparation and bioprocessing laboratory services at its BioStorage® Technologies center of excellence biorepository in Indianapolis. Brooks' expanded sample bioprocessing capabilities in Indianapolis will include a full range of sample preparation services such as volumetric and normalized aliquoting, nucleic acid extraction, blood fractionation [...]

Cloudian, ScaleMatrix and OnRamp BioInformatics Cut Storage Costs and Speed Human Genomic Data Analysis

Life-sciences ecosystem cuts storage costs by 50 percent, reduces complexity and drastically speeds data analysis of DNA sequencing and interpretation SAN MATEO, CA --- Cloudian, Inc., a global leader in enterprise object storage systems, today announced it is working with ScaleMatrix and OnRamp BioInformatics to improve efficiencies of data analysis and storage for life sciences [...]

Merck uses Genedata Biologics to Scale-Up Bispecific Antibody Discovery Programs

Merck takes advantage of latest Genedata Biologics functionalities to streamline the design, production, and testing of bispecific antibodies across their therapeutic R&D programs Basel, Switzerland - Genedata, a leading provider of advanced software solutions for R&D, today announced that Merck, a leading science and technology company, has implemented Genedata Biologics™ to scale-up their bispecific antibody [...]

Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research

Advanta Immuno-Oncology Gene Expression Assay enables efficient screening of 170 highly informative genes involved in human checkpoint therapeutic response SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expression Assay, an optimized qPCR assay that enables efficient interrogation of tumor immunobiology using proven Fluidigm® microfluidic technology. Designed for [...]

Novogene and Pacific Biosciences to Jointly Develop and Co-Market Novel Applications Based on Sequel Platform

SAN DIEGO and MENLO PARK, Calif. -- Novogene, a leading global provider of genomic services and solutions, and Pacific Biosciences of California, Inc. (NASDAQ:PACB), the leader in long-read sequencing, have agreed to jointly develop and promote novel applications based on the PacBio® Sequel® System. New applications developed under this agreement are expected to focus on basic [...]

Acquisition of Oxford Cryosystems Limited by Judges Scientific plc

Judges Scientific announces that its majority owned subsidiary Bordeaux Acquisition Limited (“Bordeaux”) has today acquired Oxford Cryosystems Ltd, the global leader in cryogenic devices for X-ray crystallography research. Oxford Cryosystems specialises in the design and manufacture of devices used to cryogenically cool crystalline samples during X-ray crystallography experiments, allowing users to investigate the structure of [...]

Agilent Technologies Presents Thought Leader Award to Dr. Ram Sasisekharan

Influential MIT Researcher Recognized for Advancing the Use of Analytical Techniques and Multilayer Analysis for Characterization of Biopharmaceuticals  SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Ram Sasisekharan, Ph.D., has received an Agilent Thought Leader Award in recognition of his contributions in the field of biologics characterization. A more efficient development of [...]

MyDx Files Complaint Against Former Chief Operating Officer, Protects Unique AeroDx Diagnostic Platform and Addresses Toxic Financier’s Unauthorized Conversion

SAN DIEGO -- MyDx, Inc. (OTCQB:MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer initially designed for cannabis professionals and retail consumers to measure the chemicals in cannabis and track their feedback on how each sample is impacting their physiology, today announced that all previously reported variable [...]

QUANTERIX BOOSTS INVESTMENTS IN ITS ACCELERATOR LAB TO SUPPORT RAPID GROWTH OF SIMOA TECHNOLOGY

Lexington, Mass. – Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced investments in Quanterix’ state-of-the-art Simoa Accelerator Lab services, including the appointment of Dr. Daniel Sikkema, Ph.D., as Vice President of Accelerator Services. Quanterix’ Simoa technology and its growing Accelerator Lab services are enabling biotechnology [...]

Hans E. Bishop to Join Agilent’s Board of Directors

CEO of Juno Therapeutics brings deep knowledge of the biopharma industry SANTA CLARA, Calif. Agilent Technologies, Inc. (NYSE: A) today announced that Hans E. Bishop, CEO of Juno Therapeutics, has been elected to its board of directors. Bishop co-founded Juno Therapeutics, a Seattle-based biopharmaceutical company, in 2013. As president and CEO, Bishop leads Juno as [...]

Access IBO on Knowledge Center